Literature DB >> 8522977

Characterization of agonist-induced down-regulation of NMDA receptors in cerebellar granule cell cultures.

A Resink1, M Villa, D Benke, H Hidaka, H Möhler, R Balázs.   

Abstract

Exposure of cerebellar granule cells to NMDA in culture at 5 days in vitro, when cells are not yet vulnerable to NMDA, evoked a pronounced reduction in NMDA receptor activity, measured by NMDA-induced 45Ca2+ influx, and counteracted the normal developmental increase in NMDA receptors. The effect was concentration and time dependent, the half-maximal effect being reached at about 45 microM and by 4-5 h. The decrease in NMDA receptor function was accompanied by a significant reduction in the protein level of the obligatory NMDA receptor subunit (NR) NR1. Both parameters remained at a low level as long as the agonist was present. However, receptor down-regulation was reversible, as receptor protein levels and NMDA responses were restored to control values upon NMDA removal, this process requiring protein synthesis. NMDA treatment also elicited a decrease in NR1, NR2A, and NR2B subunit messenger RNA (mRNA) levels. However, in comparison with NMDA receptor proteins, the decrease was faster, and NMDA receptor mRNA content recovered to control levels within 24 h in spite of the presence of NMDA. Concerning the mechanisms of agonist-induced regulation of NMDA receptor expression, it seems that protein kinase C-mediated protein phosphorylation is not involved, whereas inhibition of Ca2+/calmodulin-dependent kinase II/IV by KN-62 does depress NMDA receptor expression even in the absence of NMDA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8522977     DOI: 10.1046/j.1471-4159.1996.66010369.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Opposing effects of excitatory amino acids on chick embryo spinal cord motoneurons: excitotoxic degeneration or prevention of programmed cell death.

Authors:  J Lladó; J Calderó; J Ribera; O Tarabal; R W Oppenheim; J E Esquerda
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 2.  Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function.

Authors:  Ana Sanchez-Perez; Marta Llansola; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 3.  Challenges for basic research in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; K A Strauss; S I Goodman; G F Hoffmann; J G Okun; D M Koeller
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Intrauterine hypoxia-ischemia alters expression of the NMDA receptor in the young rat brain.

Authors:  Z Cai; P G Rhodes
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

5.  Changes in the glutamate release and uptake of cerebellar cells in perinatally nicotine-exposed rat pups.

Authors:  D K Lim; H S Kim
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

6.  Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells.

Authors:  C Brandoli; A Sanna; M A De Bernardi; P Follesa; G Brooker; I Mocchetti
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

7.  Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor.

Authors:  Li He; Joseph A Kim; Jennifer L Whistler
Journal:  FASEB J       Date:  2009-08-13       Impact factor: 5.191

8.  Combined actions of Na/K-ATPase, NCX1 and glutamate dependent NMDA receptors in ischemic rat brain penumbra.

Authors:  Sungjin Park; Yongwook Jung
Journal:  Anat Cell Biol       Date:  2010-09-30

9.  Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade.

Authors:  G Andrew Mickley; Cynthia L Kenmuir; Colleen A McMullen; Alicia Snyder; Anna M Yocom; Deborah Likins-Fowler; Elizabeth L Valentine; Bettina Weber; Jaclyn M Biada
Journal:  BMC Pharmacol       Date:  2004-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.